{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T21:12:54Z","timestamp":1725916374310},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.prp.2014.05.006","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T15:33:20Z","timestamp":1400772800000},"page":"596-602","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin"],"prefix":"10.1016","volume":"210","author":[{"given":"Franziska","family":"Berger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene","family":"Geddert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Faller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arno","family":"Dimmler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2014.05.006_bib0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0560.1992.tb01561.x","article-title":"Abnormal expression of epidermal growth factor receptor in cutaneous epithelial tumours","volume":"19","author":"Groves","year":"1992","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.prp.2014.05.006_bib0010","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2010.09751.x","article-title":"Refractory aggressive keratoacanthoma centrifugum marginatum of the scalp controlled with the epidermal growth factor receptor inhibitor erlotinib","volume":"163","author":"Bulj","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.prp.2014.05.006_bib0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10147-010-0047-8","article-title":"Treatment of multiple keratoacanthomas with erlotinib","volume":"15","author":"Reid","year":"2010","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.prp.2014.05.006_bib0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/02841860903302913","article-title":"Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias","volume":"49","author":"Stagno","year":"2010","journal-title":"Acta Oncol."},{"key":"10.1016\/j.prp.2014.05.006_bib0025","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1200\/JCO.2010.34.1735","article-title":"Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin","volume":"29","author":"Maubec","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2014.05.006_bib0030","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-06-0913","article-title":"Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting","volume":"12","author":"Sok","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2014.05.006_bib0035","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/hed.20831","article-title":"Identification of the rare EGFR mutation p.G796S as somatic and germline mutation in white patients with squamous cell carcinoma of the head and neck","volume":"30","author":"Schwentner","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.prp.2014.05.006_bib0040","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1600-0625.2011.01334.x","article-title":"Low incidence of EGFR and HRAS mutations in cutaneous squamous cell carcinomas of a German cohort","volume":"20","author":"Mauerer","year":"2011","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.prp.2014.05.006_bib0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.prp.2011.03.002","article-title":"Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy","volume":"207","author":"Uribe","year":"2011","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2014.05.006_bib0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1289\/ehp.919319","article-title":"Pellicer, ras activation in human tumors and in animal model systems","volume":"93","author":"Corominas","year":"1991","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.prp.2014.05.006_bib0205","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1105358","article-title":"RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors","volume":"366.","author":"Su","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2014.05.006_bib0055","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1158\/1078-0432.CCR-08-3286","article-title":"Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients","volume":"15","author":"Harradine","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2014.05.006_bib0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng.780","article-title":"Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1","volume":"43","author":"Goudie","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2014.05.006_bib0065","series-title":"Differential Diagnosis in Dermatopathology","author":"Ackerman","year":"1982"},{"key":"10.1016\/j.prp.2014.05.006_bib0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2407-7-156","article-title":"TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study","volume":"7","author":"Bacman","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2014.05.006_bib0075","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI24399","article-title":"Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis","volume":"115","author":"Han","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2014.05.006_bib0080","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1158\/0008-5472.CAN-04-1032","article-title":"Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation","volume":"64","author":"Lu","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2014.05.006_bib0085","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S1286-4579(99)00251-8","article-title":"TGF-beta and cancer","volume":"1","author":"Reiss","year":"1999","journal-title":"Microbes Infect."},{"key":"10.1016\/j.prp.2014.05.006_bib0090","first-page":"303","article-title":"The role for transforming growth factor-beta (TGF-beta) in human cancer","volume":"10","author":"Gold","year":"1999","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.prp.2014.05.006_bib0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/cr.2008.316","article-title":"Roles of TGFbeta in metastasis","volume":"19","author":"Padua","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.prp.2014.05.006_bib0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1087-0024.2005.200403.x","article-title":"Current view of the role of transforming growth factor beta 1 in skin carcinogenesis","volume":"10","author":"Li","year":"2005","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.prp.2014.05.006_bib0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1523-1747.2002.01834.x","article-title":"Ultraviolet irradiation alters transforming growth factor beta\/smad pathway in human skin in vivo","volume":"119","author":"Quan","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prp.2014.05.006_bib0110","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.mad.2004.11.006","article-title":"Alteration of the TGF-beta\/SMAD pathway in intrinsically and UV-induced skin aging","volume":"126","author":"Han","year":"2005","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.prp.2014.05.006_bib0115","first-page":"2722","article-title":"Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression","volume":"118","author":"Hoot","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2014.05.006_bib0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1158\/1078-0432.CCR-11-1344","article-title":"Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1","volume":"18","author":"Arnault","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2014.05.006_bib0130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00000372-199308000-00007","article-title":"Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases","volume":"15","author":"Hodak","year":"1993","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.prp.2014.05.006_bib0135","first-page":"83","article-title":"Interphase-FISH examinations in paraffin sections from benign, precancerous, and cancerous lesions of the skin and oral mucosa","volume":"10","author":"Dimmler","year":"1997","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2014.05.006_bib0140","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/jid.2012.104","article-title":"Array comparative genomic hybridization of keratoacanthomas and squamous cell carcinomas: different patterns of genetic aberrations suggest two distinct entities","volume":"132","author":"Li","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prp.2014.05.006_bib0145","first-page":"308","article-title":"The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma","volume":"103","author":"Corbalan-Velez","year":"2012","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.prp.2014.05.006_bib0150","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2230.2011.04118.x","article-title":"The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma","volume":"36","author":"Fujii","year":"2011","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.prp.2014.05.006_bib0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/PAI.0b013e3181f7b2f0","article-title":"Glut-1 expression and in situ CD1a\/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients","volume":"19","author":"Cabibi","year":"2011","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2014.05.006_bib0160","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/ijc.24197","article-title":"The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma","volume":"124","author":"Vasiljevic","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2014.05.006_bib0165","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2559.2009.03375.x","article-title":"Immunoexpression of Bcl-x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology","volume":"55","author":"Tan","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2014.05.006_bib0170","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/030089160709300310","article-title":"Beta-catenin and CD44 expression in keratoacanthoma and squamous cell carcinoma of the skin","volume":"93","author":"Tataroglu","year":"2007","journal-title":"Tumori"},{"key":"10.1016\/j.prp.2014.05.006_bib0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2559.2005.02155.x","article-title":"Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers","volume":"47","author":"Slater","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2014.05.006_bib0180","first-page":"251","article-title":"Cytokeratin 10 and Ki-67 nuclear marker expression in keratoacanthoma and squamous cell carcinoma","volume":"12","author":"Basta-Juzbasic","year":"2004","journal-title":"Acta Dermatovenerol. Croat."},{"key":"10.1016\/j.prp.2014.05.006_bib0185","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2133.2001.04459.x","article-title":"The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma","volume":"145","author":"Papadavid","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.prp.2014.05.006_bib0190","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/archderm.1991.01680070067007","article-title":"Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas","volume":"127","author":"Ho","year":"1991","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.prp.2014.05.006_bib0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00000372-199002000-00005","article-title":"Utility of peanut agglutinin (PNA) in the diagnosis of squamous cell carcinoma and keratoacanthoma","volume":"12","author":"Kannon","year":"1990","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.prp.2014.05.006_bib0200","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1524-4725.1985.tb01396.x","article-title":"H, peanut lectin receptor, and carcinoembryonic antigen distribution in keratoacanthomas, squamous dysplasias, and carcinomas of skin","volume":"11","author":"Ariano","year":"1985","journal-title":"J. Dermatol. Surg. Oncol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033814001617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033814001617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T19:07:48Z","timestamp":1565464068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033814001617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0344033814001617"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2014.05.006","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2014.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}